Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan versus atenolol plus hydrochlorothiazide crossover trial on microcirculation in hypertension
2005-003958-94Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of valsartan, atenolol and hydrochlorothiazide in essential hypertension (2 arms), sponsored by Novartis. Started Sep 2005; status: completed.
02
Drugs
valsartanatenololhydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2005-003958-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003958-94.